Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557–88.
Article PubMed PubMed Central Google Scholar
Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7:1–17.
Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13:261–80.
Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512–22.
Article PubMed PubMed Central Google Scholar
Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39(Suppl 1):19–31.
Asombang AW, Chishinga N, Mohamed MF, Nkhoma A, Chipaila J, Nsokolo B, et al. Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes. BMC Gastroenterol. 2023;23:66.
Article PubMed PubMed Central Google Scholar
Mthunzi RJ, Noel CB. Geographic distribution of pancreaticobiliary malignancy in central South Africa presenting to the universitas academic hospital complex. S Afr J Surg. 2023;61(3):7–11.
Ohira M, Kobayashi T, Hashimoto M, Tazawa H, Abe T, Oshita A, et al. Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study. Int J Surg. 2018;54:156–62.
European Association for the Study of the Liver. EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol. 2023;79(1):181–208. https://doi.org/10.1016/j.jhep.2023.03.010.
Vogel A, Bridgewater J, Edeline J, Kelley RK, Klümpen HJ, Malka D, et al. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:127–40.
Article CAS PubMed Google Scholar
Hamaoka M, Kozaka K, Matsui O, Komori T, Matsubara T, Yoneda N, et al. Early detection of intrahepatic cholangiocarcinoma. Jpn J Radiol. 2019;37:669–84.
Article CAS PubMed Google Scholar
Cardinale V. Classifications and misclassification in cholangiocarcinoma. Liver Int. 2019;39:260–2.
Kendall T, Verheij J, Gaudio E, Evert M, Guido M, Goeppert B, et al. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 2019;39:7–18.
Article CAS PubMed Google Scholar
Gong SC, An S, Shin IS, Jung PY. Usefulness of Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Treatment of Traumatic Pancreatic Injury in Children. Diagnostics. 2023;13:2044.
Article PubMed PubMed Central Google Scholar
Meseeha M, Attia M. Endoscopic Retrograde Cholangiopancreatography. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Oct 6]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK493160/
Huang Y-C, Wu C-H, Lee MH, Wang SF, Tsou Y-K, Lin C-H, et al. Timing of endoscopic retrograde cholangiopancreatography in the treatment of acute cholangitis of different severity. World J Gastroenterol. 2022;28:5602–13.
Article PubMed PubMed Central Google Scholar
Di Martino M, Ielpo B, Pata F, Pellino G, Di Saverio S, Catena F, et al. Timing of cholecystectomy after moderate and severe acute biliary pancreatitis. JAMA Surg. 2023;158(10):e233660. https://doi.org/10.1001/jamasurg.2023.3660.
Lien M-Y, Chou C-H, Lin C-C, Bai L-Y, Chiu C-F, Yeh S-P, et al. Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study. PLoS ONE. 2018;13:e0197851.
Article PubMed PubMed Central Google Scholar
Park TY, Yang YJ, Shin SP, Bang CS, Suk KT, Baik GH, et al. Candidemia after endoscopic retrograde cholangiopancreatography in an immunocompetent patient: A case report and literature review. Saudi J Gastroenterol. 2018;24:135–7.
Article PubMed PubMed Central Google Scholar
Binda C, Gibiino G, Coluccio C, Sbrancia M, Dajti E, Sinagra E, et al. Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases. Microorganisms. 2022;10:312.
Article PubMed PubMed Central Google Scholar
Chaiteerakij R. Clinical Epidemiology of Cholangiocarcinoma. In: Tabibian JH, editor. Diagnosis and Management of Cholangiocarcinoma: A Multidisciplinary Approach [Internet]. Cham: Springer International Publishing; 2021 [cited 2024 Jan 17]. p. 137–62. https://doi.org/10.1007/978-3-030-70936-5_5
Pascale A, Rosmorduc O, Duclos-Vallée J-C. New epidemiologic trends in cholangiocarcinoma. Clin Res Hepatol Gastroenterol. 2023;47:102223.
Article CAS PubMed Google Scholar
World Health Organization. The world health organization fungal priority pathogens list to guide research development and public health. Available from: https://www.who.int/publications/i/item/9789240060241. Accessed 27 June 2024
Rothe K, Rasch S, Wantia N, Poszler A, Ulrich J, Schlag C, et al. Aspergillus fumigatus cholangitis in a patient with cholangiocarcinoma: case report and review of the literature. Infection. 2021;49:159–64.
Zhang L, Chen C, Chai D, Kuang T, Deng W, Wang W. Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma. Front Microbiol. 2022;13:1090392.
Hosseini K, Ahangari H, Chapeland-Leclerc F, Ruprich-Robert G, Tarhriz V, Dilmaghani A. Role of Fungal Infections in Carcinogenesis and Cancer Development: A Literature Review. Adv Pharm Bull. 2022;12:747–56.
Zhang K, Hu J, Zhao Z. Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2. PLoS ONE. 2023;18:e0289024.
Article CAS PubMed PubMed Central Google Scholar
Yuchong C, Dingheng Z, Zhizhong Y, Hongyu Y, Jing H, Jianghan C. Aspergillosis of biliary tract after liver transplantation: a case report. Mycopathologia. 2010;170:117–21.
Liew Y, Teo J, Too I, Ngan C, Tan A, Chlebicki M, et al. Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution. BMC Infect Dis. 2015;15:256.
Article PubMed PubMed Central Google Scholar
Lockhart SR. Candida auris and multidrug resistance: Defining the new normal. Fungal Genet Biol. 2019;131:103243.
Article CAS PubMed Google Scholar
Khillan V, Rathore N, Kathuria S, Chowdhary A. A rare case of breakthrough fungal pericarditis due to fluconazole-resistant Candida auris in a patient with chronic liver disease. JMM Case Rep. 2014;1:e003707.
Toledo B, Deiana C, Scianò F, Brandi G, Marchal JA, Perán M, et al. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives. Expert Rev Clin Pharmacol. 2024;17:323–47. https://doi.org/10.1080/17512433.2024.2319340.
Nara S, Sano T, Ojima H, Onaya H, Ikeda M, Morizane C, et al. Liver cryptococcosis manifesting as obstructive jaundice in a young immunocompetent man: report of a case. Surg Today. 2008;38:271–4.
Oladele R, Uwanibe JN, Olawoye IB, Ettu AWO, Meis JF, Happi CT. Emergence and Genomic Characterization of Multidrug Resistant Candida auris in Nigeria, West Africa. J Fungi. 2022;8:787.
Achilonu CC, Davies A, Kanu OO, Noel CB, Oladele R. Recent advances and future perspectives in mitigating invasive antifungal-resistant pathogen aspergillus fumigatus in Africa. Curr Treat Options Infect Dis. 2023;15:1–20.
Loschi M, Thill C, Gray C, David M, Bagatha M-F, Chamseddine A, et al. Invasive aspergillosis in neutropenic patients during hospital renovation: effectiveness of mechanical preventive measures in a prospective cohort of 438 patients. Mycopathologia. 2015;179:337–45.
Zhong M, Xiong Y, Zhao J, Gao Z, Ma J, Wu Z, et al. Candida albicans disorder is associated with gastric carcinogenesis. Theranostics. 2021;11:4945–56.
Article CAS PubMed PubMed Central Google Scholar
Schmalzle SA, Buchwald UK, Gilliam BL, Riedel DJ. Cryptococcus neoformans infection in malignancy. Mycoses. 2016;59:542–52.
Comments (0)